SCHEMBL19729280

SCHEMBL19729280

CC(=O)C(Cc1ccccc1)N(C(C)C)C(C)C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
ALPI P09923 1/20 0.47
PKM P14618 1/20 0.47
PTGS1 P23219 1/20 0.47
XIAP P98170 1/20 0.47
SLC7A5 Q01650 1/20 0.47
HPGD P15428 1/20 0.46
CYP1A2 P05177 1/20 0.46
ALDH1A1 P00352 1/20 0.45
MAPT P10636 1/20 0.45
LMNA P02545 1/20 0.45
TRPA1 O75762 1/20 0.43
CTRB1 P17538 2/20 0.42
MAOA P21397 1/20 0.42
SLC6A2 P23975 1/20 0.42
SLC6A4 P31645 1/20 0.42
SLC6A3 Q01959 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22384110 0.87 CYP1A2 (0.52) MEN1KMT2ANPC1RAB9AALPI
SCHEMBL7266285 0.87 CYP1A2 (0.52) MEN1KMT2ANPC1RAB9AALPI
SCHEMBL12837980 0.84 HPGD (0.49) MEN1KMT2ANPC1RAB9AALPI
SCHEMBL19729270 0.84 ESR1 (0.53) SLC7A5MAPTSLC6A2TAAR1
SCHEMBL19542979 0.84 NPC1 (0.46) MEN1KMT2ANPC1RAB9AALPI
SCHEMBL890230 0.81 ALDH1A1 (0.59) MEN1KMT2ANPC1RAB9AALPI
SCHEMBL8605469 0.81 ALDH1A1 (0.59) MEN1KMT2ANPC1RAB9AALPI
SCHEMBL12341937 0.81 ALDH1A1 (0.59) MEN1KMT2ANPC1RAB9AALPI
SCHEMBL30533843 0.80 ALDH1A1 (0.58) MEN1KMT2ANPC1RAB9AALPI
SCHEMBL27904279 0.80 ALDH1A1 (0.58) MEN1KMT2ANPC1RAB9AALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183253-A1 NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY RHODE ISLAND HOSPITAL 2023-06-15 US disclosed
US-20170362238-A1 NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY RHODE ISLAND HOSPITAL 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170362238-A1 NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY POLRMT, NT5C3B, CHMP4B MEN1 125/4885KMT2A 2925/4885NPC1 2059/4885
US-20230183253-A1 NANOMATERIAL COMPOSITIONS, SYNTHESIS, AND ASSEMBLY POLRMT, NT5C3B, CHMP4B MEN1 125/4885KMT2A 2925/4885NPC1 2059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.